Champions Oncology Inc (CSBR) — Capital Reinvestment Ratio
Latest as of July 2025:
0.08x
Champions Oncology Inc (CSBR) has a Capital Reinvestment Ratio of 0.08x as of July 2025, meaning it reinvests 0% of its operating cash flow ($600.00K) in capital expenditures ($46.00K). See CSBR free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.08x
Capex / Operating Cash Flow
Operating Cash Flow
$600.00K
USD
Capital Expenditures
$46.00K
USD
Data as of
Jul 2025
Most recent filing
Champions Oncology Inc Capital Reinvestment Ratio (1997–2025)
This chart tracks Champions Oncology Inc's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Champions Oncology Inc (1997–2025)
Year-by-year Capital Reinvestment Ratio for Champions Oncology Inc from 1997 to 2025. For live market cap and broader valuation context, see Champions Oncology Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | $7.39 Million | $389.00K | ▼ -92.7% |
| 2023 | 0.73x | $3.96 Million | $2.87 Million | ▲ +97.9% |
| 2022 | 0.37x | $6.50 Million | $2.38 Million | ▼ -52.0% |
| 2020 | 0.76x | $2.90 Million | $2.22 Million | ▲ +70.6% |
| 2019 | 0.45x | $1.86 Million | $834.00K | ▲ +92.2% |
| 2001 | 0.23x | $144.68K | $33.72K | ▲ +156.4% |
| 1999 | 0.09x | $110.00K | $10.00K | ▲ +90.9% |
| 1998 | 0.05x | $420.00K | $20.00K | ▼ -47.6% |
| 1997 | 0.09x | $110.00K | $10.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow